Stock screener

MBX

Conviction 80HealthcareScan · Mon, Aug 10, 2026
MBX$65.96-2.74%
ResistanceSupportVol 14Insider sell
63 bars
Vol MA14 526.23K
May 11May 28Jun 16Jul 6Jul 23Aug 10
MBX Biosciences, Inc.PHARMACEUTICAL PREPARATIONSwww.mbxbio.com ↗
Price65.96
Change-2.74%
Gap-0.91%
Rel volume0.57×
Avg volume645.39K
Avg $ vol40.32M
SMA 2063.20
SMA 5052.13
SMA 20036.55
Price vs 50+26.52%
Price vs 200+80.46%
MA stackbullish
50/200 cross—
Supertrendup · 55.34
RSI (14)59
MACD hist-0.34
MACD cross—
Stoch %K / %D57 / 63
ADX (14)36
+DI / −DI28 / 14
RSI divergence—
MACD divergence—
ATR %+6.81%
ADR %7.57%
52w high70.70
52w low9.75
From 52w high-6.70%
Above 52w low+576.86%
New 52w highNo
SqueezeOff
Bollinger width23.25%
%B0.69
Donchian pos66.82%
Donchian high72.64
Donchian low52.51
AVWAP (52w high)67.55
vs AVWAP high-2.35%
AVWAP (52w low)31.42
vs AVWAP low+109.96%
OBV trendFlat
Chaikin MF (20)0.15
Today vs 20d0.57×
Avg vol (14d)526.23K
Avg vol (20d)645.39K
Avg $ vol (20d)40.32M
Market cap3.18B
RS 3m (vs SPY)+89.69%
RS 6m (vs SPY)+74.01%
RS line new highNo
Trend template8/8
Technical rank88.5
1 week+2.41%
1 month+8.04%
3 months+61.02%
6 months+75.10%
1 year+492.63%
YTD+115.91%
P/E-36.53
P/B7.76
P/S—
P/FCF-38.80
EPS-2.38
Div yield—
ROE-21.24%
ROA-19.95%
Debt/Eq—
Current18.08
EV/EBITDA—
Gross margin—
Net margin—
Rev growth—
EPS growth-40.45%
Price target87.56
Target upside32.75%
Analyst ratingBuy
Institutional114.48%
Ent. value3.12B
Revenue—
Net income-37.09M
Gross profit—
Free cash flow-81.88M
IndustryPHARMACEUTICAL PREPARATIONS
ExchangeNasdaq
Shares out47.6M
Employees63
ListedFri, Sep 13, 2024
Free float28.64M
Float %60.2%
Short interest5.78M
Days to cover6.2d
Short volume62.6%
Squeeze score80 / 100
Next earnings—
EPS forecast—
Last EPS vs est−$0.78 vs −$0.68
Last surprise-14.7% miss
Setup gradeA
Conviction80 / 100
Pattern quality—
Tech rank88.5 / 100
Group rank86 / 100 · Leading
Status laneNo active setup
Setup direction—
Pattern family
Resistance69.65
Support54.87
Days since event—
Candle confirm—
News sentiment—

Financials as of Tue, Jun 30, 2026 · quarterly.

Signal lifecycle

How this symbol has moved through the lanes across 46 scans — each scan is re-classified from that day's price, so gaps are days it dropped off the board entirely.

  1. Setting up
    Jul 23 – Aug 3
    5 scans
  2. Breaking out now
    Aug 4
    1 scan
  3. Broke out
    Aug 5
    1 scan
  4. Retesting breakout
    Aug 6
    1 scan

Congress activity

Disclosed STOCK Act trades in MBX

All disclosures →
No recent disclosed trades by Congress in MBX. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in MBX · 7 buys · 1 sell

InsiderSideShares
Azoulay Salomon
Chief Medical Officer · Common Stock · 2026-08-04
Sell370
Hoerter Steven L.
Director · Stock option (right to buy) · 2026-06-04
Grant12.5K
Mathers Edward T
Director · Stock option (right to buy) · 2026-06-04
Grant12.5K
Ryder Steven
Director · Stock option (right to buy) · 2026-06-04
Grant12.5K
Hoerter Steven L.
Director · Common Stock · 2026-06-04
Other—
Pescovitz Ora H.
Director · Common Stock · 2026-06-04
Other—
Pescovitz Ora H.
Director · Stock option (right to buy) · 2026-06-04
Grant12.5K
Stelzer Laurie
Director · Stock option (right to buy) · 2026-06-04
Grant12.5K
Heron Patrick J
Director · Stock option (right to buy) · 2026-06-04
Grant12.5K
Aynechi Tiba
Director · Stock option (right to buy) · 2026-06-04
Grant12.5K

SEC filings

EDGAR filings in MBX · 10 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.